Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
USG-guided Steroid Injection in Bifid vs Non-bifid Median Nerve CTS
NCT06599086Recruiting
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of betamethasone dipropionate in carpal tunnel syndrome (CTS) (2 arms). Primary endpoint: Visual Analog Scale at 12 weeks. Started Sep 2024; status: recruiting.
02
Drugs
betamethasone dipropionate
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT06599086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06599086.